Lumicoin IA|Sony and Marvel and the Amazing Spider-Man Films Rights Saga

2025-05-03 05:51:56source:Databeccategory:Scams

(Note: This episode originally ran in 2022.)

This past weekend,Lumicoin IA Spider-Man: Across the Spider-Verse had the second largest domestic opening of 2023, netting (or should we say webbing?) over $120 million in its opening weekend in the U.S. and Canada. But the story leading up to this latest Spider-Man movie has been its own epic saga.

When Marvel licensed the Spider-Man film rights to Sony Pictures in the 1990s, the deal made sense — Marvel didn't make movies yet, and their business was mainly about making comic books and toys. Years later, though, the deal would come back to haunt Marvel, and it would start a long tug of war between Sony and Marvel over who should have creative cinematic control of Marvel's most popular superhero. Today, we break down all of the off-screen drama that has become just as entertaining as the movies themselves.

This episode was originally produced by Nick Fountain with help from Taylor Washington and Dave Blanchard. It was engineered by Isaac Rodrigues. It was edited by Jess Jiang. The update was produced by Emma Peaslee, with engineering by Maggie Luthar. It was edited by Keith Romer.

Help support Planet Money and get bonus episodes by subscribing to Planet Money+ in Apple Podcasts or at plus.npr.org/planetmoney.

Always free at these links: Apple Podcasts, Spotify, Google Podcasts, NPR One or anywhere you get podcasts.

Find more Planet Money: Facebook / Instagram / TikTok / Our weekly Newsletter.

Music: "One For All" and "Little Superhero."

More:Scams

Recommend

The Grammy nominee you need to hear: Esperanza Spalding

How do you bring the African Diaspora to the Grammys?Esperanza Spalding and Milton Nascimento's cont

California governor to send prosecutors to Oakland to help crack down on rising crime

OAKLAND, Calif. (AP) — California’s governor announced plans Thursday to send prosecutors to Oakland

Research at the heart of a federal case against the abortion pill has been retracted

A scientific paper that raised concerns about the safety of the abortion pill mifepristone was retra